...
首页> 外文期刊>Neurochemical Research >Plasma Ceruloplasmin Ferroxidase Activity Correlates with the Nigral Sonographic Area in Parkinson’s Disease Patients: A Pilot Study
【24h】

Plasma Ceruloplasmin Ferroxidase Activity Correlates with the Nigral Sonographic Area in Parkinson’s Disease Patients: A Pilot Study

机译:一项帕金森氏病患者血浆铜蓝蛋白铁氧化酶活性与黑色素超声检查区域相关

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Increased area of the substantia nigra (SN) associated to iron deposition has been proposed as a specific marker for Parkinson’s disease (PD). Echogenicity, assessed by transcranial sonography (TCS), has been used to measure such an iron deposition. On the other hand, ferroxidase activity is known to play a role in brain iron metabolism and thus could be involved in increased SN echogenicity of PD patients. The present study was conducted to search for a possible correlation between both markers: TCS of SN and plasma ferroxidase activity. Twenty-one PD patients and 13 healthy volunteers (HV) were included. Mean SN sonographic areas were 0.31 cm2 for PD patients and 0.12 cm2 for HV (P < 0.001), while plasma ferroxidase activity was reduced in PD patients (P < 0.001). Interestingly, plasma ferroxidase activity was inversely correlated with the SN size by TCS (R2 = 0.31), suggesting a relationship between the two markers.
机译:与铁沉积有关的黑质(SN)面积增加已被提议作为帕金森氏病(PD)的特定标志物。通过经颅超声检查(TCS)评估的致电子性已用于测量这种铁沉积。另一方面,已知过氧化铁酶活性在脑铁代谢中起作用,因此可能与PD患者的SN回声增加有关。进行本研究以寻找两个标记:SN的TCS和血浆亚铁氧化酶活性之间的可能相关性。包括21名PD患者和13名健康志愿者(HV)。 PD患者的平均SN超声检查面积为0.31 cm 2 ,HV为0.12 cm 2 (P <0.001),而PD患者的血浆铁过氧化物酶活性降低(P <0.001) )。有趣的是,血浆铁过氧化物酶活性与TCS的SN大小呈负相关(R 2 = 0.31),表明这两个标记之间存在关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号